Shilanski & Associates’s DaVita DVA Stock Holding History
Bought
Maintained
Sold
Other funds holding DVA
GCM
Shilanski & Associates's DVA Position: Q2 2021 in Review
Shilanski & Associates sold out of DaVita (DVA) in Q2 2021, closing a stake of 8,638 shares — an estimated $931K sold.
Shilanski & Associates first reported a position in DVA in Q2 2020 and held it in 4 quarters. The position peaked at $1.03M in Q4 2020. 515 funds tracked by Wall St. Rank hold DVA as of Q2 2021.
- Shilanski & Associates reported no remaining DaVita position as of Q2 2021 after selling out during the quarter.
- Shilanski & Associates sold 8,638 DaVita shares in Q2 2021, an estimated $931K.
- Shilanski & Associates first reported a position in DaVita in Q2 2020 and held it in 4 quarters.
- Shilanski & Associates's DaVita position peaked at $1.03M in Q4 2020.
- 515 funds tracked by Wall St. Rank held DaVita as of Q2 2021.
Based on Shilanski & Associates's 13F filing for Q2 2021, filed 13 Aug 2021.